Division of Cardiac Surgery, Schulich Heart Centre, Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Temerty School of Medicine, University of Toronto, Toronto, Ontario, Canada.
Braz J Cardiovasc Surg. 2022 Sep 2;37(Spec 1):7-31. doi: 10.21470/1678-9741-2022-0142.
The second best conduit for coronary artery bypass grafting is uncertain. The objective of this study is to determine the second best conduit according to graft patency results from randomized controlled trials using a network meta-analysis.
A systematic literature search was conducted for randomized controlled trials comparing the angiographic patency rate of the no-touch saphenous vein (NT-SV), the radial artery (RA), the right internal thoracic artery (RITA), and the gastroepiploic artery (GEA) in reference to the conventionally harvested saphenous vein (CON-SV). The primary outcome was graft occlusion, and the secondary outcome was all-cause mortality.
A total of 859 studies were retrieved, of which 18 were included. A total of 6,543 patients and 8,272 grafts were analyzed. The weighted mean angiographic follow-up time was 3.5 years. Compared with CON-SV, RA (incidence rate ratio [IRR] 0.56; 95% confidence interval [CI], 0.43-0.74) and NT-SV (IRR 0.56; 95% CI, 0.44-0.70) demonstrated lower graft occlusion. NT-SV and RA were ranked as the best conduits (rank score for NT-SV 0.88 vs. 0.87 for RA, 0.29 for GEA, 0.27 for CON-SV, and 0.20 for RITA). There was no significant difference in late mortality between different conduit types.
RA and NT-SV are associated with significantly lower graft occlusion rates and are comparably ranked as the best conduit for patency.
冠状动脉旁路移植术的第二选择不确定。本研究的目的是通过网络荟萃分析,根据随机对照试验的血管通畅率结果来确定第二选择。
系统地检索了比较非接触式隐静脉(NT-SV)、桡动脉(RA)、右内乳动脉(RITA)和胃网膜动脉(GEA)与常规采集隐静脉(CON-SV)的血管造影通畅率的随机对照试验。主要结局是移植物闭塞,次要结局是全因死亡率。
共检索到 859 项研究,其中 18 项被纳入。共分析了 6543 例患者和 8272 个移植物。加权平均血管造影随访时间为 3.5 年。与 CON-SV 相比,RA(发生率比 [IRR] 0.56;95%置信区间 [CI],0.43-0.74)和 NT-SV(IRR 0.56;95% CI,0.44-0.70)的移植物闭塞率较低。NT-SV 和 RA 被认为是最佳的移植物(NT-SV 的排名分数为 0.88,RA 为 0.87,GEA 为 0.29,CON-SV 为 0.27,RITA 为 0.20)。不同移植物类型之间的晚期死亡率无显著差异。
RA 和 NT-SV 与较低的移植物闭塞率相关,且通畅性排名相似,均为最佳移植物。